3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
56
Neoplasm Metastasis
3
Stage II Prostate Adenocarcinoma
1
Sleep Initiation and Maintenance Disorders
1
Salivary Gland Neoplasms
1
Prostate Cancer Metastatic Disease
1
Prostate Cancer Metastatic
1
Non-metastatic Castration-resistant Prostate Cancer
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Metastatic Hormone-sensitive Prostate Cancer
1
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
1
Metastatic Castration-resistant Prostate Neoplasms
1
Metastatic Castration-Resistant Prostate Cancer
1
Metastatic Castrate-sensitive Prostate Cancer
1
Low Risk Prostate Cancer
1
Fatigue
1
Depression
1
Castration Levels of Testosterone
1
Adenocarcinoma
1
Interventions
gedatolisib
1
gallium 68 PSMA-11
1
darolutamide
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
(225)Ac-PSMA-617
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Genital Diseases, Male
×
apalutamide
×
1 year
×
Clear all
No trials found.